February 12, 2020 / 12:40 PM / in 12 days

BRIEF-Kala Pharma Posts Q4 Loss Per Share Of $0.63

Feb 12 (Reuters) - Kala Pharmaceuticals Inc:

* KALA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.63

* Q4 EARNINGS PER SHARE ESTIMATE $-0.60 — REFINITIV IBES DATA

* KALA PHARMACEUTICALS - EXPECTS EXISTING CASH RESOURCES, TOGETHER WITH PROJECTED INVELTYS REVENUE, WILL ENABLE IT TO FUND OPERATIONS INTO Q2 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below